These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 24488656)

  • 21. Two-dimensional spectroscopic imaging for pretreatment evaluation of prostate cancer: comparison with the step-section histology after radical prostatectomy.
    Weis J; Ahlström H; Hlavcak P; Häggman M; Ortiz-Nieto F; Bergman A
    Magn Reson Imaging; 2009 Jan; 27(1):87-93. PubMed ID: 18599244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. (31) P MR spectroscopic imaging combined with (1) H MR spectroscopic imaging in the human prostate using a double tuned endorectal coil at 7T.
    Luttje MP; Italiaander MG; Arteaga de Castro CS; van der Kemp WJ; Luijten PR; van Vulpen M; van der Heide UA; Klomp DW
    Magn Reson Med; 2014 Dec; 72(6):1516-21. PubMed ID: 24357271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MR spectroscopic imaging and diffusion-weighted imaging of prostate cancer with Gleason scores.
    Nagarajan R; Margolis D; Raman S; Sarma MK; Sheng K; King CR; Verma G; Sayre J; Reiter RE; Thomas MA
    J Magn Reson Imaging; 2012 Sep; 36(3):697-703. PubMed ID: 22581787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Three-dimensional proton MR spectroscopy of human prostate at 3 T without endorectal coil: feasibility.
    Scheenen TW; Heijmink SW; Roell SA; Hulsbergen-Van de Kaa CA; Knipscheer BC; Witjes JA; Barentsz JO; Heerschap A
    Radiology; 2007 Nov; 245(2):507-16. PubMed ID: 17848681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Refined modelling of the short-T2 signal component and ensuing detection of glutamate and glutamine in short-TE, localised, (1) H MR spectra of human glioma measured at 3 T.
    Gottschalk M; Troprès I; Lamalle L; Grand S; Le Bas JF; Segebarth C
    NMR Biomed; 2016 Jul; 29(7):943-51. PubMed ID: 27197077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined use of diffusion-weighted MRI and 1H MR spectroscopy to increase accuracy in prostate cancer detection.
    Reinsberg SA; Payne GS; Riches SF; Ashley S; Brewster JM; Morgan VA; deSouza NM
    AJR Am J Roentgenol; 2007 Jan; 188(1):91-8. PubMed ID: 17179350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
    Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
    Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-invasive estimation of prostate cancer aggressiveness using diffusion-weighted MRI and 3D proton MR spectroscopy at 3.0 T.
    Thörmer G; Otto J; Horn LC; Garnov N; Do M; Franz T; Stolzenburg JU; Moche M; Kahn T; Busse H
    Acta Radiol; 2015 Jan; 56(1):121-8. PubMed ID: 24504488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy.
    Zakian KL; Sircar K; Hricak H; Chen HN; Shukla-Dave A; Eberhardt S; Muruganandham M; Ebora L; Kattan MW; Reuter VE; Scardino PT; Koutcher JA
    Radiology; 2005 Mar; 234(3):804-14. PubMed ID: 15734935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TE = 32 ms vs TE = 100 ms echo-time (1)H-magnetic resonance spectroscopy in prostate cancer: Tumor metabolite depiction and absolute concentrations in tumors and adjacent tissues.
    Basharat M; Payne GS; Morgan VA; Parker C; Dearnaley D; deSouza NM
    J Magn Reson Imaging; 2015 Oct; 42(4):1086-93. PubMed ID: 26258905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MR Spectroscopy in Prostate Cancer: New Algorithms to Optimize Metabolite Quantification.
    Bellomo G; Marcocci F; Bianchini D; Mezzenga E; D'Errico V; Menghi E; Zannoli R; Sarnelli A
    PLoS One; 2016; 11(11):e0165730. PubMed ID: 27832096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MRI in the detection of prostate cancer: combined apparent diffusion coefficient, metabolite ratio, and vascular parameters.
    Riches SF; Payne GS; Morgan VA; Sandhu S; Fisher C; Germuska M; Collins DJ; Thompson A; deSouza NM
    AJR Am J Roentgenol; 2009 Dec; 193(6):1583-91. PubMed ID: 19933651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Automated vs. manual pattern recognition of 3D (1)H MRSI data of patients with prostate cancer.
    Zechmann CM; Menze BH; Kelm BM; Zamecnik P; Ikinger U; Giesel FL; Thieke C; Delorme S; Hamprecht FA; Bachert P
    Acad Radiol; 2012 Jun; 19(6):675-84. PubMed ID: 22578226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional MR imaging of prostate cancer.
    Choi YJ; Kim JK; Kim N; Kim KW; Choi EK; Cho KS
    Radiographics; 2007; 27(1):63-75; discussion 75-7. PubMed ID: 17234999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative analysis of prostate metabolites using 1H HR-MAS spectroscopy.
    Swanson MG; Zektzer AS; Tabatabai ZL; Simko J; Jarso S; Keshari KR; Schmitt L; Carroll PR; Shinohara K; Vigneron DB; Kurhanewicz J
    Magn Reson Med; 2006 Jun; 55(6):1257-64. PubMed ID: 16685733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo (1)H MRSI of glycine in brain tumors at 3T.
    Ganji SK; Maher EA; Choi C
    Magn Reson Med; 2016 Jan; 75(1):52-62. PubMed ID: 25651788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reproducibility of 3D 1H MR spectroscopic imaging of the prostate at 1.5T.
    Lagemaat MW; Zechmann CM; Fütterer JJ; Weiland E; Lu J; Villeirs GM; Holshouser BA; van Hecke P; Lemort M; Schlemmer HP; Barentsz JO; Roell SO; Heerschap A; Scheenen TW
    J Magn Reson Imaging; 2012 Jan; 35(1):166-73. PubMed ID: 21960013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proton MR spectroscopy of the prostate.
    Mueller-Lisse UG; Scherr MK
    Eur J Radiol; 2007 Sep; 63(3):351-60. PubMed ID: 17709223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. (31) P MR spectroscopic imaging of the human prostate at 7 T: T1 relaxation times, Nuclear Overhauser Effect, and spectral characterization.
    Lagemaat MW; Maas MC; Vos EK; Bitz AK; Orzada S; Weiland E; van Uden MJ; Kobus T; Heerschap A; Scheenen TW
    Magn Reson Med; 2015 Mar; 73(3):909-20. PubMed ID: 24677408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined MRI and MRS in prostate cancer: improvement of spectral quality by susceptibility matching.
    Scheidler J; Vogel M; Gross P; Heuck A
    Rofo; 2009 Jun; 181(6):531-5. PubMed ID: 19353482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.